[1]
K. Styczkiewicz, D. Sawka, and M. Styczkiewicz, “Tyrosine kinase inhibitors – should we worry about cardiovascular complications?”, OncoReview, vol. 7, no. 2(26), pp. 70-77, Apr. 2017.